Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SYMPATHY: Esomeprazole Management Strategies in GERD
NCT00343161Phase 4Completed
- Sponsor
- AstraZeneca
- Start
- Aug 2006
- Primary completion
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of esomeprazole in gastroesophageal reflux disease (GERD), sponsored by AstraZeneca. Started Aug 2006; status: completed.
02
Drugs
esomeprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT00343161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00343161.